January 20-22th, 2011 / San Francisco, USA Chemotherapy-induced neutropenia association with survival in metastatic colorectal cancer: schedule-dependency. Innominato P.F., Giacchetti S., Smaaland R., Focan C., Garufi C., Bjarnason G., Iacobelli S., Tumolo S., Karaboué A., Levi F. J Clin Oncol 29: 2011 (suppl 4; abstr 454).
lire la suite
January 19 -21st 2012 / San Francisco, USA
January 19 -21st 2012 / San Francisco, USA Relations between systemic chemotherapy exposure and treatment effects in patients on hepatic artery infusion of chronomodulated triplet and intravenous cetuximab for liver metastases from colorectal cancer. A companion study to OPTILIV european phase II trial. F. Levi, A. Karaboué, M. C. Etienne-Grimaldi, E. Chatelut, P. F. Innominato,…
lire la suite
January 24-26th 2013 / San Francisco, USA
January 24-26th 2013 / San Francisco, USA Final results of first European phase II trial of intravenous cetuximab and hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colo-rectal cancer after systemic treatment failure (OPTILIV, NCT00852228). Levi F., Boige V., Hebbar M., Smith D.M., Lepère C., Focan…
lire la suite